You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Endocrine Surgery
 •Gastrointestinal/ Upper Foregut
 •Oncology, Other
 •Alert me on articles by topic

Improved Survival for Adenocarcinoma of the Ampulla of Vater

Fifty-five Consecutive Resections

John P. Duffy, MD; Oscar J. Hines, MD; Jerome H. Liu, MD; Clifford Y. Ko, MD; Galen Cortina, MD; William H. Isacoff, MD; Henry Nguyen, BS; Michael Leonardi, BS; Ronald K. Tompkins, MD; Howard A. Reber, MD

Arch Surg. 2003;138:941-950.

Hypothesis  After resection of an adenocarcinoma of the ampulla of Vater, certain clinical and pathologic characteristics influence long-term survival.

Design  Retrospective case series.

Setting  Major academic medical and pancreatic surgical center.

Patients  Fifty-five consecutive patients who underwent Whipple resection for ampullary adenocarcinoma from 1988 through 2001.

Interventions  Pylorus-preserving Whipple resection in 32 patients and standard Whipple resection in 23 patients.

Main Outcome Measures  Postoperative survival. A multivariate Cox proportional hazards model was used to determine the effects of various factors on long-term survival after resection.

Results  There were no operative deaths, and all patients left the hospital. After a mean follow-up of 46.9 months, the overall 5-year Kaplan-Meier survival estimate was 67.7%. The median survival of the entire group has not yet been reached. Five-year postoperative survival estimates for node-negative (n = 32) and node-positive patients (n = 23) were 76.5% and 53.4%, respectively (P = .26). Patients whose tumors demonstrated perineural invasion (n = 12) had a 5-year survival estimate of 29.2% vs 78.8% for those whose did not (P<.001). On multivariate analysis, the absence of perineural invasion (P<.001) was an independent predictor of significantly improved postoperative survival.

Conclusions  Compared with previous reports from our own and other centers, this series demonstrates improved postoperative survival by 10% to 20% in patients undergoing Whipple resection for adenocarcinoma of the ampulla of Vater. The reasons for this improved outcome are unclear, and the effect of adjuvant treatment cannot be determined from this analysis. The major factor associated with prolonged survival was the absence of perineural invasion in the resected tumor specimen.


From the Section of Gastrointestinal Surgery (Drs Duffy, Hines, Liu, Ko, Tompkins, and Reber, and Messrs Nguyen and Leonardi), and the Departments of Pathology (Dr Cortina) and Medicine (Dr Isacoff), the David Geffen School of Medicine at the University of California–Los Angeles.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recurrence and Prognostic Factors of Ampullary Carcinoma after Radical Resection: Comparison with Distal Extrahepatic Cholangiocarcinoma
Woo et al.
Ann. Surg. Oncol. 2007;14:3195-3201.
ABSTRACT | FULL TEXT  

Effect of Neoadjuvant Chemoradiation on Operative Mortality and Morbidity for Pancreaticoduodenectomy
Cheng et al.
Ann. Surg. Oncol. 2006;13:66-74.
ABSTRACT | FULL TEXT  

Effect of Antecolic Reconstruction on Delayed Gastric Emptying After the Pylorus-Preserving Whipple Procedure
Hartel et al.
Arch Surg 2005;140:1094-1099.
ABSTRACT | FULL TEXT  

Pancreaticoduodenectomy Is Curative in the Majority of Patients With Node-Negative Ampullary Cancer
Brown et al.
Arch Surg 2005;140:529-533.
ABSTRACT | FULL TEXT  

Carcinoma of the Ampulla of Vater: A Distinct Disease Entity?
Conlon
Ann. Surg. Oncol. 2003;10:1136-1137.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.